当前位置：首页 > 文献互助 > 互助详情

From Concept to Clinic: Cutting-Edge Advances Steering the Next Wave of Antibody–Drug Conjugates Innovation复制

用户KjOiVFBXV5FU 2小时前 8 10 待确认 帖子自动结束时间: 2026-03-31 13:53:45

1. 请及时下载文件确认是否正确, 系统将在 2026-04-02 15:33:21 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/j.jddst.2026.108271复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1773224726002960复制

其他信息:

出版社: Elsevier BV
作者: Imsha Parveen; Anjlina Aqil; Sumit Sharma; Abdul Qadir; Sayed Abdur Rehman; Ashif Iqubal; Khang Wen Goh; Rajath Govind; Mohammad Kashif Iqubal; Prashant Kesharwani

上一篇：Hematological toxicities in antibody–drug conjugates related with breast cancer: a pharmacovigilance study using FDA adverse event reporting system database

下一篇：A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide

互助时间线

2026-03-26 15:33:21 [上传文件]

小小奇迹上传了文件(pdf 2.40 MB), 求助状态变成 待确认

2026-03-26 13:53:45 [发起求助]

最新发布的求助

The Thermal and Photochemical Behavior of the Cyclomers Derived from 1,1′-(1,3-Propanediyl)bis(pyridinyl) Diradicals 15分钟前
Spatial and temporal organization during cardiac fibrillation 33分钟前
Universities are embracing AI: will students get smarter or stop thinking? 40分钟前
Two-year outcomes of repeated red light therapy in premyopic children: sustained efficacy and rebound effects 43分钟前
Drug-drug interaction by metabolites: Challenges and solutions during therapeutics innovation 52分钟前
Spiral Waves of Chemical Activity 57分钟前
Pulmonary hypertension 1小时前
Challenging the Consensus Statement: Is It Time to Recognise Pharmacological Remission of Type 2 Diabetes? 1小时前
Targeted therapeutic options based on the pathogenesis of IgA nephropathy 1小时前
Highly Antibacterial and Self-Healing Janus Fabric for Effective Body Moisture/Thermal Management and Durable Waterproof 1小时前
Dupilumab and neuropsychiatric outcomes in pediatric atopic dermatitis: A real-world cohort analysis 1小时前
Real-World Japanese Study of the Effectiveness and Safety of Switching From Dupilumab to Lebrikizumab in Patients with Moderate to Severe Atopic Dermatitis 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com